| A Study of Oral ARD-101 in Patients With Prader-Willi Syndrome (NCT05153434) | Aardvark Therapeutics, Inc. | 2022-05-27 |
| Biological Age Assessment in Adults With Prader-Willi Syndrome (ETABIOLPWS) (NCT05778032) | Istituto Auxologico Italiano | 2022-05-25 |
| Characterization of Serum Proteome in Subjects With Prader Willi Syndrome (PROTEOMARKER) (NCT05761184) | Istituto Auxologico Italiano | 2022-04-28 |
| A Study to Assess RAD011 (Cannabidiol Oral Solution) for the Treatment of Participants With Prader-Willi Syndrome (NCT05098509) | Radius Pharmaceuticals, Inc. | 2022-04-13 |
| Effect of Intranasal Oxytocin on Dysphagia in Children and Adolescents With Prader-Willi Syndrome (NCT05298085) | University Hospital, Toulouse | 2022-04-05 |
| Study of Tesomet With Open-label Extension in Subjects With Prader-Willi Syndrome (NCT05198362) | Saniona | 2021-12-28 |
| Improving Care of Prader-Willi Syndrome : Evaluation of a New Care Program Combining Adapted Physical Activity, Nutrition and Therapeutic Education (NCT05249998) | Assistance Publique - Hôpitaux de Paris | 2021-11-06 |
| Long-term Interventional Follow-up Study of Children With Prader-Willi Syndrome Included in the OTBB3 Clinical Trial (NCT05032326) | University Hospital, Toulouse | 2021-09-07 |
| Ghrelin in Patients With a Rare Disease Associated With Intellectual Disability, and Hyperphagia, and/or Overweight, and/or Obesity (NCT04768803) | University Hospital, Toulouse | 2021-06-10 |
| Study of the Efficacy and Safety of Somatropin in Japanese Participants With PWS (NCT04697381) | Pfizer | 2021-02-09 |
| Guanfacine Extended Release for the Reduction of Aggression and Self-injurious Behavior Associated With Prader-Willi Syndrome (NCT05657860) | Maimonides Medical Center | 2020-12-17 |
| A Phase 2 Study to Evaluate the Safety and Efficacy of Pitolisant in Patients With Prader-Willi Syndrome, Followed by an Open Label Extension (NCT04257929) | Harmony Biosciences Management, Inc. | 2020-12-09 |
| CBDV vs Placebo in Children and Adults up to Age 30 With Prader-Willi Syndrome (PWS) (NCT03848481) | Eric Hollander | 2020-11-23 |
| Study of Emotion and Cognition Abilities of Children With PWS and Proposition of an Innovative Remediation (NCT04526379) | University Hospital, Toulouse | 2020-09-07 |
| tVNS in Children With Prader-Willi Syndrome (NCT04396470) | Stanford University | 2020-07-01 |
| Assessment of CAI in Adults With PWS. (NCT04700644) | Medical University of Warsaw | 2020-05-15 |
| Oxytocin Treatment in Neonates and Infants With Prader-Willi Syndrome (NCT04283578) | University Hospital, Toulouse | 2020-03-10 |
| Dose Clinical Trial of Guanfacine Extended Release for the Reduction of Aggression and Self-injuries Behavior Associated With Prader-Willi Syndrome (NCT04066088) | NYU Langone Health | 2019-12-01 |
| An Open-Label Study of DCCR Tablet in Patients With PWS (NCT04086810) | Soleno Therapeutics, Inc. | 2019-10-01 |
| PWS Outcomes Assessment Study (NCT04102839) | Soleno Therapeutics, Inc. | 2019-07-15 |
| Fiber Intervention on Gut Microbiota in Children With Prader-Willi Syndrome (NCT04150991) | University of Alberta | 2019-07-01 |
| Stress and Brain Response Using MEG in PWS (NCT04032639) | The Hospital for Sick Children | 2019-05-30 |
| Home-based SSP on Individuals With PWS (NCT03871751) | Indiana University | 2019-04-08 |
| Effects of Livoletide (AZP-531) on Food-related Behaviors in Patients With Prader-Willi Syndrome (NCT03790865) | Millendo Therapeutics SAS | 2019-03-25 |
| Parent and Infant Inter(X)Action Intervention (PIXI) (NCT03836300) | RTI International | 2018-11-30 |
| Phase 3 Study of Intranasal Carbetocin (LV-101) in Patients With Prader-Willi Syndrome (NCT03649477) | Levo Therapeutics, Inc. | 2018-11-20 |
| Early Check: Expanded Screening in Newborns (NCT03655223) | RTI International | 2018-10-15 |
| GROWing Up With Rare GENEtic Syndromes (NCT04463316) | dr. Laura C. G. de Graaff-Herder | 2018-10-01 |
| Open-Label Extension Study of DCCR in PWS Followed by Double-Blind, Placebo-Controlled, Randomized Withdrawal Period (NCT03714373) | Soleno Therapeutics, Inc. | 2018-10-01 |
| Natural History Study of Serious Medical Events in PWS (NCT03718416) | Foundation for Prader-Willi Research | 2018-09-28 |
| A Study to Assess the Long-Term Safety of Pharmaceutical Grade Synthetic Cannabidiol Oral Solution in Participants With Prader-Willi Syndrome (NCT03458416) | Radius Pharmaceuticals, Inc. | 2018-09-06 |
| A Study of Diazoxide Choline in Patients With Prader-Willi Syndrome (NCT03440814) | Soleno Therapeutics, Inc. | 2018-05-09 |
| Cannabidiol Oral Solution for the Treatment of Patients With Prader-Willi Syndrome (NCT02844933) | Radius Pharmaceuticals, Inc. | 2018-05-09 |
| A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone Injection in Patients With Prader-Willi Syndrome (NCT03554031) | Changchun GeneScience Pharmaceutical Co., Ltd. | 2018-04-14 |
| Intranasal Oxytocin vs. Placebo for the Treatment of Hyperphagia in Prader-Willi Syndrome (NCT03197662) | Eric Hollander | 2018-04-11 |
| A Study of GLWL-01 in Patients With Prader-Willi Syndrome (NCT03274856) | GLWL Research Inc. | 2018-02-20 |
| Targeting the Gut Microbiome for Prader-Willi Syndrome Treatment (NCT03548480) | Fundació Sant Joan de Déu | 2018-01-01 |
| Optimizing the Social Engagement System in Prader-Willi Syndrome: Insights From the Polyvagal Theory (NCT03101826) | Indiana University | 2017-11-01 |
| Intranasal Oxytocin for Infants With Prader-Willi Syndrome (NCT03245762) | University of Florida | 2017-08-01 |
| A 5 Treatment Period Pharmacokinetic Study Evaluating Dose Proportionality and Food Effects of Diazoxide Choline Controlled-Release Tablet (DCCR) (NCT02893618) | Essentialis, Inc. | 2017-07-01 |
| GH in Adults With PWS, Effect on Hypotonia Evaluated by Functional MRI, Relationship With Strength and Body Composition (NCT03616509) | Corporacion Parc Tauli | 2017-06-19 |
| Effects of Transcranial Direct Current Stimulation (tDCS) on Individuals With Prader-Willi Syndrome (NCT03324906) | Federal University of São Paulo | 2017-05-08 |
| Follow-up of Prader Willi Syndrome Infants Treated by Oxytocin and Comparison With Not-treated Infants. (NCT03081832) | University Hospital, Toulouse | 2017-01-01 |
| Oxytocin Intranasal Administrations in Children With Prader-Willi Syndrome Aged From 3 to 12 Years (NCT03114371) | University Hospital, Toulouse | 2016-11-28 |
| Oxygen Versus Medical Air for Treatment of CSA in Prader Will Syndrome (NCT03031626) | The Hospital for Sick Children | 2016-09-01 |
| Therapeutic Effects of Hippotherapy in Children With Prader-Willi Syndrome (NCT03858023) | Samsung Medical Center | 2016-08-01 |
| Post Exercise Irisin Levels in PWS Patients (NCT02728544) | Shaare Zedek Medical Center | 2016-04-01 |
| Effects of Progressive Elastic Band Resistance Training (NCT03565081) | Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation | 2016-02-01 |
| Proof of Concept Study of Vagus Nerve Stimulation (NCT03689621) | Jessica Beresford-Webb | 2016-01-01 |
| Oxytocin vs. Placebo for the Treatment Hyperphagia in Children and Adolescents With Prader-Willi Syndrome (NCT02629991) | Montefiore Medical Center | 2015-10-01 |
| SNP-based Microdeletion and Aneuploidy RegisTry (SMART) (NCT02381457) | Natera, Inc. | 2015-04-01 |
| Phase 2 Trial to Evaluate Safety and Efficacy of Setmelanotide (RM-493) in Obese Participants With Prader-Willi Syndrome (NCT02311673) | Rhythm Pharmaceuticals, Inc. | 2015-03-19 |
| Oxytocin Trial in Prader-Willi Syndrome (NCT02013258) | University of Florida | 2015-03-01 |
| PREPL in Health and Disease (NCT02263781) | Universitaire Ziekenhuizen KU Leuven | 2014-10-01 |
| Deep Brain Stimulation for the Treatment of Obesity in Patients With Prader-Willi Syndrome (NCT02297022) | University of Sao Paulo General Hospital | 2014-10-01 |
| Growth Hormone in Children Under 2 Years With Prader-Willi in Hospital of Sabadell (NCT02205450) | Corporacion Parc Tauli | 2014-09-01 |
| Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome (NCT02179151) | Zafgen, Inc. | 2014-09-01 |
| Effects of Intranasal Administration of Oxytocin in Adults With Prader-Willi Syndrome (NCT02804373) | University Hospital, Toulouse | 2014-06-01 |
| Study to Assess the Efficacy and Safety of Eutropin in Prader-Willi Syndrome (NCT02204163) | LG Life Sciences | 2014-06-01 |
| Prader-Willi Syndrome Macronutrient Study (NCT02011360) | Duke University | 2014-05-01 |
| Clinical Study of Diazoxide Choline Controlled-Release Tablet (DCCR) in Patients With Prader-Willi Syndrome (NCT02034071) | Essentialis, Inc. | 2014-04-01 |
| Diagnosis of Central Adrenal Insufficiency in Patients With Prader-Willi Syndrome (NCT02368379) | Nationwide Children's Hospital | 2014-03-01 |
| Hypoglycemia in Prader-Willi Syndrome (NCT01897363) | University of Florida | 2013-07-01 |
| An Efficacy, Safety, and Pharmacokinetics Study of Beloranib in Obese Subjects With Prader-Willi Syndrome (NCT01818921) | Zafgen, Inc. | 2013-06-01 |
| Evaluation of Tolerance, Suckling and Food Intake After Repeated Nasals Administrations of Oxytocin in PWS Infants (NCT02205034) | University Hospital, Toulouse | 2013-05-01 |
| Pilot Study of Startle-response Test to Assess Transcranial Direct Current Stimulation-induced Modulation of Hyperphagia in Prader-Willi Syndrome (NCT01863017) | University of Kansas Medical Center | 2013-04-01 |
| Study of the Efficacy of Topiramate in Patients With Prader Willi Syndrome Over 8 Weeks (NCT02810483) | Assistance Publique - Hôpitaux de Paris | 2012-12-01 |
| Aromatase Inhibitor in Bone Maturation, Children With Silver Russell or Prader-Willi Syndrome (NCT01520467) | Assistance Publique - Hôpitaux de Paris | 2012-04-01 |
| Liraglutide Use in Prader-Willi Syndrome (NCT01542242) | Vancouver General Hospital | 2012-02-01 |
| Bioequivalence of Two Somatropin Products (Norditropin® Versus Genotropin®) in Healthy Adult Volunteers (NCT01401244) | Novo Nordisk A/S | 2011-07-14 |
| Tolerance of Intranasal Administration of OT in Prader-Willi Newborn Babies (NCT01548521) | University Hospital, Toulouse | 2011-07-01 |
| Sleep Abnormalities in Rare Genetic Disorders: AS, RTT, and PW (NCT02670694) | Baylor College of Medicine | 2011-06-01 |
| Family-based Intervention for Youth With Prader-Willi Syndrome: The Active Play at Home Study (NCT02058342) | California State University, Fullerton | 2011-05-01 |
| The Intestinal Function in People With Prader-Willi Syndrome (NCT01523288) | Aarhus University Hospital | 2011-02-01 |
| Comparative Study Between Prader-Willi Patients Who Take Oxytocin Versus Placebo (NCT01038570) | University Hospital, Toulouse | 2009-06-01 |
| Register of Patients With Prader-Willi Syndrome (NCT02829684) | University Hospital, Toulouse | 2009-03-01 |
| Cortisol Activity in Patients With Prader-Willi Syndrome and Healthy Controls (NCT00932932) | Children's Mercy Hospital Kansas City | 2009-02-01 |
| Is There a Sensibility Increased in the Growth Hormone at Child With Prader-Willi Syndrome? (NCT01298180) | University Hospital, Toulouse | 2009-01-01 |
| Exploring Stress and Coping Behaviors of the Major Carer Whose Children With Prader-Willi Syndrome (NCT00808548) | Taichung Veterans General Hospital | 2008-12-01 |
| Retrospective Observational Study on Efficacy and Safety of Norditropin® in Children With Prader-Willi Syndrome (NCT00705172) | Novo Nordisk A/S | 2008-11-01 |
| Behavioral Treatment of Obsessive-Compulsive Symptoms in Youth With Prader-Willi Syndrome: A Pilot Project (NCT00742664) | University of South Florida | 2008-09-01 |
| Gut Derived Hormones, Body Composition and Metabolism in Prader-Willi Syndrome (NCT00551343) | Garvan Institute of Medical Research | 2007-10-01 |
| Effect of Rimonabant on Weight Gain and Body Composition in Adults With Prader Willi Syndrome (NCT00603109) | Weill Medical College of Cornell University | 2007-08-01 |
| Plasma Adiponectin Level and Vascular Endothelial and Smooth Muscle Cell Function in Children With Prader-Willi Syndrome (NCT01479322) | Samsung Medical Center | 2007-01-01 |
| Plasma Adiponectin Level and Sleep Structures in Children With Prader-Willi Syndrome (NCT01622751) | Samsung Medical Center | 2007-01-01 |
| Octreotide Therapy in Children and Young Adults With Prader-Willi Syndrome (PWS) (NCT00399893) | Duke University | 2006-12-01 |
| Characteristics of Prader-Willi Syndrome and Early-onset Morbid Obesity (NCT00375089) | University of Florida | 2006-09-01 |
| Correlation of Hyperghrelinemia With Carotid Artery Intima-Media Thickness in Children With Prader-Willi Syndrome (NCT00474643) | Samsung Medical Center | 2006-08-01 |
| Nordic Study on the Effects of Growth Hormone (Norditropin SimpleXx) Treatment in Adults With Prader-Willi Syndrome (NCT00372125) | Karolinska University Hospital | 2005-04-01 |
| Characterization of Transcriptional Regulators of Ghrelin Hormone Which Causes Genetic Obesity (NCT01404624) | Samsung Medical Center | 2005-01-01 |
| Prader-Willi Syndrome and Appetite (NCT00175305) | University of British Columbia | 2004-08-01 |
| Macronutrient Regulation of Ghrelin and Peptide YY (NCT02464514) | Duke University | 2004-01-01 |
| Treatment of Self-Injurious Behavior in Individuals With Prader-Willi Syndrome (NCT00065923) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2002-07-01 |
| Study of Phenotype and Genotype Correlations in Patients With Contiguous Gene Deletion Syndromes (NCT00004351) | National Institute of Neurological Disorders and Stroke (NINDS) | 1999-09-01 |